Exelixis Inc. buy melinda
Start price
14.03.16
/
50%
€3.66
Target price
19.05.16
€5.41
Performance (%)
31.15%
End price
19.05.16
€4.80
Summary
This prediction ended on 19.05.16 with a price of €4.80. The BUY prediction by melinda for Exelixis Inc. saw massive gains of 31.15%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Exelixis Inc. | 5.602% | 5.602% | 23.454% | 151.527% |
| iShares Core DAX® | -1.862% | 0.670% | 0.920% | 51.849% |
| iShares Nasdaq 100 | -3.322% | 4.989% | 33.716% | 86.850% |
| iShares Nikkei 225® | -2.299% | 6.129% | 52.955% | 63.321% |
| iShares S&P 500 | -1.313% | 3.399% | 24.674% | 66.112% |
Comments by melinda for this prediction
In the thread Exelixis Inc. diskutieren
métastase rénale
cancer
(Vom Mitglied beendet)


